Please enable JavaScript or talk to your local administrator to get JavaScript enabled.


Modeling bladder cancer metastasis using human patient-derived tumor organoids

Funder: Bladder Cancer Advocacy Network

Funding period
USD 300 K
Funding amount
The molecular mechanisms that regulate progression of bladder cancer to invasion and metastasis are poorly understood, in part due to the lack of suitable model systems that reflect the biology of the human disease. In recent work, we have used three-dimensional culture approaches to establish a novel biobank of human patient-derived organoids from primary bladder tumors. These organoid lines recapitulate the histopathological and molecular diversity of non-muscle invasive bladder cancer as well as muscle invasive bladder cancer, and can be readily converted into xenografts by orthotopic transplantation. We hypothesize that these patient-derived organoid lines represent a suitable model for functional analyses of bladder cancer metastasis, and will therefore pursue three specific aims: 1) Investigation of tumor invasiveness in organoid culture to examine the roles of extracellular matrix and tumor-specific mutations in conferring invasive properties to bladder tumor cells; 2) Molecular analysis of metastasis by orthotopic transplantation of organoids to analyze the metastatic ability of organoid-derived xenografts in vivo; and 3) Investigation of collective invasion and dissemination using multi-color organoids to determine whether metastasis is mediated by single cells or multicellular (collective) clusters. Overall, this proposal represents a highly innovative project that uses human patient-derived tumor organoids to identify tumor cell autonomous and microenvironmental factors that regulate progression to metastatic bladder cancer.
Similar projects All >
Sorted by: Start Date
Project list item
DNA adductome of human bladder from the tobacco exposome

National Institute of Environmental Health Sciences to ROBERT J. TURESKY

USD 467,974
2019 - 2023
Project list item
Chromatin Modifier Gene Mutation and Enhancer Dysfunction in Bladder Cancer

National Cancer Institute to BYRON H LEE

USD 243,205
2019 - 2024
Project list item
Combatting Bladder Cancer by Inducing Epithelial Turnover

National Cancer Institute to SOMAN N ABRAHAM

USD 203,510
2019 - 2021
Project list item
Phase 1/2 Study of Modern Immunotherapy in BCG-Relapsing Urothelial Carcinoma of the Bladder - (ADAPT-BLADDER)

National Cancer Institute to NOAH M HAHN

USD 656,816
2019 - 2024
Project list item
Defining the impact of intra-tumoral morphologic, immune and mutational heterogeneity in urothelial carcinoma

National Cancer Institute to HIKMAT AL-AHMADIE

USD 410,835
2019 - 2024



    1112 Oncology and Carcinogenesis

  • RCDC


  • RCDC


  • RCDC

    Urologic Diseases




    2.1 Biological and endogenous factors

  • Health Research Areas


  • Broad Research Areas

    Basic Science